In one of the first studies that evaluated BIRC5 expression in bone marrow samples using qPCR, the researchers reported positive expression in more than half of the ALL samples (8 out of 13), while the majority of chronic lymphocytic leukemia (CLL) cases (20 out of 21) exhibited strong expression [47]. This evidence concerns the gene BIRC5 and B-cell chronic lymphocytic leukemia.